https://www.selleckchem.com/pr....oducts/protokylol-hy
1% (95% CI 31.4%-49.5%). Moreover, individuals with high polygenic risk achieved greater benefits in terms of absolute risk reductions from adherence to ideal fasting blood glucose and total cholesterol than those with low polygenic risk. Maintaining favorable cardiovascular health (CVH) profile could substantially mitigate the increased risk conferred by high polygenic risk to the level of the low polygenic risk (from 34.6 % to 13.2%). Our metaPRS has great potential for risk stratification of stroke and identification
Like
Comment
Share
